Bipolar Disorder (BD) Clinical Trials

13 recruiting

Bipolar Disorder (BD) Trials at a Glance

14 actively recruiting trials for bipolar disorder (bd) are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Çankırı, Aurora, and Beijing. Lead sponsors running bipolar disorder (bd) studies include Babes-Bolyai University, Centre Hospitalier St Anne, and Akrivia Health.

Browse bipolar disorder (bd) trials by phase

Treatments under study

About Bipolar Disorder (BD) Clinical Trials

Looking for clinical trials for Bipolar Disorder (BD)? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bipolar Disorder (BD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bipolar Disorder (BD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

A Study of Home-use Brain Stimulation to Treat Bipolar Depression

Bipolar Disorder (BD)
King's College London212 enrolled1 locationNCT07556692
Recruiting
Not Applicable

Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents

AdolescentsBipolar Disorder (BD)Bipolar Disorder I or II+2 more
University of California, Los Angeles80 enrolled4 locationsNCT06920940
Recruiting
Not Applicable

PROgram To Enhance Cardiovascular Risk Trough an Intervention of Nutrition in Bipolar Disorder

Bipolar DepressionBipolar Disorder (BD)
University of Sao Paulo88 enrolled1 locationNCT06488573
Recruiting
Not Applicable

Epigenetic Enhancement of Cognitive Training in Aging Mood Disorder Populations

Cognitive ImpairmentDepression - Major Depressive DisorderBipolar Disorder (BD)
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital160 enrolled1 locationNCT07404085
Recruiting
Phase 1Phase 2

Adaptation and Validation of the Hypomanic Personality Scale (HPS-6) to Romanian

Bipolar Disorder (BD)
Babes-Bolyai University50 enrolled1 locationNCT07399626
Recruiting
Not Applicable

Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder

PsychosisBipolar Disorder (BD)
McMaster University10 enrolled1 locationNCT07213492
Recruiting
Not Applicable

Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders

Depressive DisorderSchizophreniaNeurologic Disorders+1 more
Centre Hospitalier St Anne600 enrolled3 locationsNCT07295652
Recruiting

Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life

Bipolar Disorder (BD)Schizophenia Disorder
Çankırı Karatekin University150 enrolled1 locationNCT07306468
Recruiting
Not Applicable

Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

Primary CareMajor DepressionBipolar Disorder (BD)+1 more
University Hospital, Montpellier623 enrolled1 locationNCT07031817
Recruiting

Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental Illness

DementiaSchizophrenia DisordersBipolar Disorder (BD)+1 more
Akrivia Health50,000 enrolled1 locationNCT06641726
Recruiting

Real-world Lithium Intake

Bipolar Disorder (BD)
University of Aarhus50 enrolled1 locationNCT07167563
Recruiting
Not Applicable

Development and Application of Precision Treatment Strategies for Common Mental Disorders

Depression - Major Depressive DisorderSchizophrenia DisordersBipolar Disorder (BD)
Peking University600 enrolled1 locationNCT06729541
Recruiting
Not Applicable

Stress Management with Real-time Bio-signal Biofeedback

Bipolar Disorder (BD)Major Depressive Diorder
Seoul National University Hospital100 enrolled1 locationNCT06616116
Recruiting

Using the web to improve knowledge and self-management of Bipolar Disorder: A randomised controlled trial

Newly diagnosed (within six months) Bipolar Disorder (BD).
Dr Judy Proudfoot, Black Dog Institute, University of NSW300 enrolled1 locationACTRN12608000411347